FDA Law

JANUARY 4, 2023

Brevig, Senior Regulatory Device and Biologics Expert — On December 7, 2022, FDA’s Center for Biologics Evaluation and Research (CBER) and the Office of Tissues and Advanced Therapies (OTAT) held a town hall to answer questions related to cell therapy and tissue-engineered products chemistry, manufacturing, and contr­­ols (CMC).

Manufacturing 59

Manufacturing Engineering Clinic Provider 59

Medical Xpress

JULY 1, 2025

Im hopeful that the genomic information from this and future studies will guide choices of chemotherapies, and their adoption in clinical practice." We are constantly on the lookout for better ways of giving therapy and minimizing the side effects of toxic, systemic treatments. "Im

Patients 101

Patients Individual Medical Diabetes 101

Medical Xpress

JUNE 16, 2025

The goal is to support clinical trials and bring in another $50 million in private investment to help ibogaine win approval from the U.S. A 2024 study published in the journal Nature Medicine found that military veterans with brain injuries saw major mental and physical improvements after just one ibogaine session.

Mental Health 52

Mental Health IT Specialization Medical 52

Medical Xpress

JUNE 16, 2025

This achievement is the result of an interdisciplinary collaboration among researchers in life science, physics, and computer science. Dr. Po-Ting Yeh, the studys first author, explains the challenge: "It is difficult to study the basic physiological functions controlled by the hypothalamus, which lies deep inside the brain.

Provider 111

Provider Complication Medical Diabetes 111